Scarica l'app Stockscreener
202.90
0.39%
0.53
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RMD Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Resmed Inc Borsa (RMD) Ultime notizie
ResMed Inc stock (US75102W1036): Strong earnings offset by market underperformance - AD HOC NEWS
VIRGINIA RETIREMENT SYSTEMS ET Al Has $23.83 Million Position in ResMed Inc. $RMD - MarketBeat
ResMed stock (US7611521078): Ex-dividend date arrives May 14 amid CEO option exercise - AD HOC NEWS
Swiss Life Asset Management Ltd Cuts Stake in ResMed Inc. $RMD - MarketBeat
ResMed Inc stock (AU000000RMD6): ex-dividend date approaches May 14 - AD HOC NEWS
ResMed stock (US7611521078): ex-dividend date approaches on May 14 - AD HOC NEWS
ResMed stock (US7611521078): CEO exercises options amid NYSE price drop - AD HOC NEWS
Is ResMed a Better Buy Than Stryker? - Trefis
ResMed Inc. stock rises Tuesday, outperforms market - MarketWatch
Should you buy ResMed shares at their 52-week low? - The Motley Fool Australia
ResMed stock hits 52-week low at $198.62 By Investing.com - Investing.com India
A Look at ResMed Inc (RMD) After 3.9% Decline -- GF Value $270.0 - GuruFocus
A Look at ResMed Inc (RMD) After 3.9% Decline -- GF Value $270.01 vs Price $198.76 - GuruFocus
ResMed CEO Farrell Exercises Options and Trims Stake Under 10b5-1 Plan - TipRanks
ResMed Inc. stock falls Monday, underperforms market - MarketWatch
ResMed stock hits 52-week low at $198.62 - Investing.com
ResMed Inc. stock (US7611521078): Recent price dynamics signal trading opportunities - AD HOC NEWS
ResMed (NYSE:RMD) CEO Sells $1,037,229.62 in Stock - MarketBeat
ResMed chairman and CEO Michael Farrell sells $1 million in stock - Investing.com Nigeria
Resmed Insider Sold Shares Worth $1,037,233, According to a Recent SEC Filing - marketscreener.com
ResMed (NYSE: RMD) CEO sells 4,991 shares under 10b5-1 plan - Stock Titan
Should you continue to hold Resmed stock in your portfolio? - MSN
ResMed Inc stock (AU000000RMD6): Sleep apnea and respiratory care leader posts strong growth outlook - AD HOC NEWS
ResMed (NYSE:RMD) Could Be A Buy For Its Upcoming Dividend - Yahoo Finance
ResMed Inc. stock: Earnings beat but shares slip on guidance concerns - AD HOC NEWS
Number of shareholders of ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh – LSX:935168 - TradingView
ResMed, Inc. Experiences Valuation Adjustment Amid Competitive Pharmaceuticals Sector Landscape - Markets Mojo
Mitsubishi UFJ Asset Management Co. Ltd. Increases Holdings in ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Sold by Strs Ohio - MarketBeat
RMD Stock Price, Quote & Chart | RESMED INC (NYSE:RMD) - ChartMill
ResMed expects FY 2026 gross margin of 62%-63% as it plans $175M+ Q4 buybacks and targets June 1 close for $340M Noctrix deal - MSN
ResMed Inc. stock falls Thursday, underperforms market - MarketWatch
[144] RESMED INC SEC Filing - Stock Titan
QRG Capital Management Inc. Has $5.39 Million Stock Holdings in ResMed Inc. $RMD - MarketBeat
ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions - The Globe and Mail
Resmed boosts sleep health portfolio with Noctrix buy - BioWorld News
ResMed Stock Is Down 22% in 2026: Here’s Why Analysts Still Sees $256 Fair Value - TIKR.com
Piper Sandler Maintains ResMed(RMD.US) With Hold Rating, Cuts Target Price to $233 - Moomoo
Swedbank AB Has $265.55 Million Holdings in ResMed Inc. $RMD - MarketBeat
Harel Insurance Investments & Financial Services Ltd. Decreases Stock Holdings in ResMed Inc. $RMD - MarketBeat
Wall Street's insights into key metrics ahead of ResMed (RMD) Q3 earnings - MSN
ResMed, Inc. Hits New 52-Week Low at USD 210.67 - Markets Mojo
Resmed enters merger agreement to acquire Noctrix Health for $340 million - MassDevice
9 Stocks That Could Defy the ’Sell in May and Go Away’ Trend This Time - Investing.com
Resmed integrating AI for sleep apnea treatment - Yahoo Finance
Here's Why ResMed (RMD) is a Strong Growth Stock - Yahoo Finance
Birch Capital Management LLC Reduces Stock Holdings in ResMed Inc. $RMD - MarketBeat
Stifel Nicolaus Adjusts ResMed Price Target to $235 From $265 - Moomoo
Ord Minnett Reaffirms Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) - The Globe and Mail
[Form 3] RESMED INC Initial Statement of Beneficial Ownership - Stock Titan
ResMed (RMD) CFO Brett Sandercock reports direct holding of 83,495 shares - Stock Titan
ResMed Inc. stock rises Monday, outperforms market - MarketWatch
ResMed Inc. (RMD) Stock Analysis: Exploring a 31.99% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
ResMed announces CFO succession - MSN
Market Chatter: CSL, Resmed, Cochlear Lead Losses on ASX - Moomoo
ResMed Price Target Cut 13% to A$41.72/Share by Morgans - Moomoo
CSL, Resmed, Cochlear Lead Losses on ASX - marketscreener.com
0.76%
1.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):